<unk>  is a hypoglycemic agent that is FDA approved for the treatment of type 2 diabetes mellitus.   Common adverse reactions include hypoglycemia, constipation, diarrhea, flatulence, nausea, asthenia, dizziness, feeling nervous, headache, tremor.
Glipizide
Miglitol
Acarbose
Linagliptin
Glyburide
Rosiglitazone
Pioglitazone
Liraglutide